Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley C Jordan

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Science (New York, N.Y.)|February 22, 2024
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneysShikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell ResponseJasmine T Plummer, Deisy Contreras, Wenjuan Zhang, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical ImplicationsJonathan S Bromberg, Daniel C Brennan, Emilio Poggio, et al.
The New England Journal of Medicine|August 3, 2017
IgG Endopeptidase in Highly Sensitized Patients Undergoing TransplantationStanley C Jordan, Tomas Lorant, Jua Choi, et al.
Iscience|October 3, 2022
Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccinationYapei Huang, Juliana E Shin, Alexander M Xu, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2017
Cell-Free DNA and Active Rejection in Kidney AllograftsRoy D Bloom, Jonathan S Bromberg, Emilio D Poggio, et al.
Journal of the American Society of Nephrology : JASN|October 16, 2024
Competing and Noncompeting Risk Models for Predicting Kidney Allograft FailureAgathe Truchot, Marc Raynaud, Ilkka Helanterä, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2025
Competing and Noncompeting Risk Models for Predicting Kidney Allograft FailureAgathe Truchot, Marc Raynaud, Ilkka Helanterä, et al.
Transplantation|January 3, 2020
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working GroupCarrie A Schinstock, Roslyn B Mannon, Klemens Budde, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 2, 2019
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplantRobert R Redfield, Stanley C Jordan, Stephan Busque, et al.
Science (New York, N.Y.)|February 22, 2024
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneysShikhar Aggarwal, Zhanxiang Wang, David Rincon Fernandez Pacheco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2022
US Severe Acute Respiratory Syndrome Coronavirus 2 Epsilon Variant: Highly Transmissible but With an Adjusted Muted Host T-Cell ResponseJasmine T Plummer, Deisy Contreras, Wenjuan Zhang, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical ImplicationsJonathan S Bromberg, Daniel C Brennan, Emilio Poggio, et al.
The New England Journal of Medicine|August 3, 2017
IgG Endopeptidase in Highly Sensitized Patients Undergoing TransplantationStanley C Jordan, Tomas Lorant, Jua Choi, et al.
Iscience|October 3, 2022
Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccinationYapei Huang, Juliana E Shin, Alexander M Xu, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2017
Cell-Free DNA and Active Rejection in Kidney AllograftsRoy D Bloom, Jonathan S Bromberg, Emilio D Poggio, et al.
Journal of the American Society of Nephrology : JASN|October 16, 2024
Competing and Noncompeting Risk Models for Predicting Kidney Allograft FailureAgathe Truchot, Marc Raynaud, Ilkka Helanterä, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2025
Competing and Noncompeting Risk Models for Predicting Kidney Allograft FailureAgathe Truchot, Marc Raynaud, Ilkka Helanterä, et al.
Transplantation|January 3, 2020
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working GroupCarrie A Schinstock, Roslyn B Mannon, Klemens Budde, et al.
Pageof 17